U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.334C>G (p.Leu112Val) AND Rett syndrome

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
May 10, 2022
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000012608.29

Allele description [Variation Report for NM_001110792.2(MECP2):c.334C>G (p.Leu112Val)]

NM_001110792.2(MECP2):c.334C>G (p.Leu112Val)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.334C>G (p.Leu112Val)
Other names:
NM_001110792.2(MECP2):c.334C>G; p.Leu112Val
HGVS:
  • NC_000023.11:g.154032286G>C
  • NG_007107.3:g.109818C>G
  • NM_001110792.2:c.334C>GMANE SELECT
  • NM_001316337.2:c.19C>G
  • NM_001369391.2:c.19C>G
  • NM_001369392.2:c.19C>G
  • NM_001369393.2:c.19C>G
  • NM_001369394.2:c.19C>G
  • NM_001386137.1:c.-263C>G
  • NM_001386138.1:c.-263C>G
  • NM_001386139.1:c.-263C>G
  • NM_004992.4:c.298C>G
  • NP_001104262.1:p.Leu112Val
  • NP_001303266.1:p.Leu7Val
  • NP_001356320.1:p.Leu7Val
  • NP_001356321.1:p.Leu7Val
  • NP_001356322.1:p.Leu7Val
  • NP_001356323.1:p.Leu7Val
  • NP_004983.1:p.Leu100Val
  • NP_004983.1:p.Leu100Val
  • LRG_764t1:c.334C>G
  • LRG_764t2:c.298C>G
  • AJ132917.1:c.298C>G
  • LRG_764:g.109818C>G
  • LRG_764p1:p.Leu112Val
  • LRG_764p2:p.Leu100Val
  • NC_000023.10:g.153297737G>C
  • NG_007107.2:g.109842C>G
  • NM_004992.3:c.298C>G
  • P51608:p.Leu100Val
Protein change:
L100V; LEU100VAL
Links:
UniProtKB: P51608#VAR_017462; OMIM: 300005.0027; dbSNP: rs28935168
NCBI 1000 Genomes Browser:
rs28935168
Molecular consequence:
  • NM_001386137.1:c.-263C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386138.1:c.-263C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386139.1:c.-263C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001110792.2:c.334C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316337.2:c.19C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369391.2:c.19C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369392.2:c.19C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369393.2:c.19C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369394.2:c.19C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004992.4:c.298C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Rett syndrome (RTT)
Synonyms:
Autism, dementia, ataxia, and loss of purposeful hand use; Rett's disorder
Identifiers:
MONDO: MONDO:0010726; MedGen: C0035372; Orphanet: 3095; Orphanet: 778; OMIM: 312750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000032843OMIM
no assertion criteria provided
Pathogenic
(Oct 15, 2003)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000188042RettBASE
no assertion criteria provided
Uncertain significance
(Sep 27, 2012)
de novo, unknowncuration

PubMed (5)
[See all records that cite these PMIDs]

SCV002540678ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
reviewed by expert panel

(ClinGen RettAS ACMG Specifications V2)
Pathogenic
(May 10, 2022)
germlinecuration

Citation Link,

SCV004808979Centre for Population Genomics, CPG
criteria provided, single submitter

(McKnight et al. (Hum Mutat. 2022))
Pathogenic
(Mar 13, 2024)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot provided1Nocuration
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownyes5not providednot provided5Nocuration
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms.

Buyse IM, Fang P, Hoon KT, Amir RE, Zoghbi HY, Roa BB.

Am J Hum Genet. 2000 Dec;67(6):1428-36. Epub 2000 Oct 30.

PubMed [citation]
PMID:
11055898
PMCID:
PMC1287920

Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome.

Chae JH, Hwang YS, Kim KJ.

J Child Neurol. 2002 Jan;17(1):33-6.

PubMed [citation]
PMID:
11913567
See all PubMed Citations (6)

Details of each submission

From OMIM, SCV000032843.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a patient with Rett syndrome (RTT; 312750), Buyse et al. (2000) identified a 298C-G change in the MECP2 gene, resulting in a leu100-to-val (L100V) substitution.

Hammer et al. (2003) reported a 5-year-old girl with a 47,XXX karyotype who had relatively mild atypical Rett syndrome leading initially to a diagnosis of infantile autism with regression. Mutation analysis identified a de novo L100V mutation in the MECP2 gene. The supernumerary X chromosome was maternally derived. X-inactivation patterns indicated preferential inactivation of the paternal allele. The authors suggested that the patient illustrated the importance of allele dosage on phenotypic expression.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From RettBASE, SCV000188042.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedcuration PubMed (5)
2not provided1not providedNocuration PubMed (5)
3not provided1not providedNocuration PubMed (5)
4not provided1not providednot providedcuration PubMed (5)
5not provided1not providedNocuration PubMed (5)
6not provided1not providedNocuration PubMed (5)

Description

Rett syndrome - Not certain

"Rett syndrome - Not certain"
"Rett syndrome - Classical"
"Rett syndrome - classical"
"Rett syndrome - atypical"
"Rett syndrome - not certain"
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot providednot provided
2unknownyes1Bloodnot provided1not providednot providednot provided
3unknownyes1Bloodnot provided1not providednot providednot provided
4unknownyes1bloodnot provided1not providednot providednot provided
5de novoyes1Bloodnot provided1not providednot providednot provided
6unknownyes1bloodnot provided1not providednot providednot provided

From ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel, SCV002540678.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The p.Leu100Val (NM_004992) variant has been observed in at least 5 other individuals with Rett Syndrome (PMID: 22476991, 16672765, 12966522, 11913567, 11055898, RettBASE) (PS4). The p.Leu100Val variant occurs in the well-characterized Methyl-DNA binding [MBD] functional domain of the MECP2 (PM1). The p.Leu100Val variant in MECP2 is absent from gnomAD (PM2_supporting). The p.Leu100Val variant in MECP2 occurs in the de novo state (biological parentage unconfirmed) in an individual with mild atypical Rett syndrome (PMID: 12966522)(PM6). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). In summary, the p.Leu100Val variant in MECP2 is classified as Pathogenic for Rett syndrome based on the ACMG/AMP criteria (PS4, PM1, PM6, PM2_supporting, PP3).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Centre for Population Genomics, CPG, SCV004808979.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Has been observed in at least 5 individuals with phenotypes consistent with MECP2-related disease (PS4). PMID: 22476991, 16672765, 12966522, 11913567, 11055898, ClinVar Variation ID: 11835 Occurs in the well-characterized Methyl-DNA binding (MDB) functional domain of MECP2 (PM1). This variant has been identified as a de novo occurrence in an individual with Rett syndrome without confirmation of paternity and maternity (PM6). (PMID: 12966522) Computational prediction analysis tools suggests a deleterious impact (REVEL score>= 0.75) (PP3). At least one individual with this variant has been reported with a clinical phenotype consistent with Rett syndrome (PP4). PMID: 22476991 This variant is absent from gnomAD (PM2_Supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024